Institutional investors purchased a net $1.7 million shares of SPNC during the quarter ended December 2016 and now own 91.25% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PARTNER FUND MANAGEMENT LP Bought 1.2 Million shares of Spectranetics Corp